Marcaine Spinal 7.5 mg/mL
Bupivacaine Hydrochloride in Dextrose · INJECTION, SOLUTION · Hospira, Inc.
No Recall HistoryCurrently in Shortage
Plain English
Marcaine Spinal is a injection, solution containing bupivacaine hydrochloride in dextrose at 7.5 mg/mL, taken subarachnoid. Manufactured by Hospira, Inc..
Key Facts
- Brand Name
- Marcaine Spinal
- Generic Name
- Bupivacaine Hydrochloride in Dextrose
- NDC Code (Product)
0409-1761- Manufacturer
- Hospira, Inc.
- Strength
- 7.5 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBARACHNOID
- Marketing Status
- Application #
- NDA018692
- Marketing Start
- 05/19/2005
Recall History
No Recall HistoryFrequently Asked Questions
What is Marcaine Spinal used for?
Marcaine Spinal contains Bupivacaine Hydrochloride in Dextrose. It is a injection, solution taken subarachnoid. Consult your doctor for specific uses.
Is Marcaine Spinal a controlled substance?
Marcaine Spinal is not classified as a controlled substance by the DEA.
What is the generic name for Marcaine Spinal?
The generic name for Marcaine Spinal is Bupivacaine Hydrochloride in Dextrose. There are 1 other brand versions of Bupivacaine Hydrochloride in Dextrose.
What is the NDC code for Marcaine Spinal 7.5 mg/mL?
The NDC (National Drug Code) for Marcaine Spinal 7.5 mg/mL is 0409-1761, listed by Hospira, Inc..